UK markets closed
  • FTSE 100

    7,389.98
    +87.24 (+1.19%)
     
  • FTSE 250

    19,835.95
    +146.93 (+0.75%)
     
  • AIM

    956.64
    +9.47 (+1.00%)
     
  • GBP/EUR

    1.1822
    +0.0040 (+0.34%)
     
  • GBP/USD

    1.2496
    +0.0021 (+0.17%)
     
  • BTC-GBP

    23,497.58
    -778.48 (-3.21%)
     
  • CMC Crypto 200

    650.34
    -23.03 (-3.42%)
     
  • S&P 500

    3,901.36
    +0.57 (+0.01%)
     
  • DOW

    31,261.90
    +8.77 (+0.03%)
     
  • CRUDE OIL

    110.35
    +0.46 (+0.42%)
     
  • GOLD FUTURES

    1,845.10
    +3.90 (+0.21%)
     
  • NIKKEI 225

    26,739.03
    +336.19 (+1.27%)
     
  • HANG SENG

    20,717.24
    +596.56 (+2.96%)
     
  • DAX

    13,981.91
    +99.61 (+0.72%)
     
  • CAC 40

    6,285.24
    +12.53 (+0.20%)
     

The Global Kidney Transplantation Therapeutics Market is expected to grow by $ 1.16 bn during 2022-2026, accelerating at a CAGR of 4.32% during the forecast period

·3-min read
ReportLinker
ReportLinker

Global Kidney Transplantation Therapeutics Market 2022-2026 The analyst has been monitoring the kidney transplantation therapeutics market and it is poised to grow by $ 1. 16 bn during 2022-2026, accelerating at a CAGR of 4.

New York, May 02, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Kidney Transplantation Therapeutics Market 2022-2026" - https://www.reportlinker.com/p06272634/?utm_source=GNW
32% during the forecast period. Our report on the kidney transplantation therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the rising prevalence of CKD and renal impairments, availability of drugs in multiple dosage forms, and high dependency on immunosuppressants for kidney transplantation.
The kidney transplantation therapeutics market analysis includes the product segment and geographic landscape.

The kidney transplantation therapeutics market is segmented as below:
By Product
• Selective cytokine inhibitors
• Immunosuppressive antimetabolites
• Other drugs

By Geography
• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies novel techniques for kidney transplantation as one of the prime reasons driving the kidney transplantation therapeutics market growth during the next few years. Also, reimbursement policies for kidney transplantation and increasing strategic alliances will lead to sizable demand in the market.

The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on kidney transplantation therapeutics market covers the following areas:
• Kidney transplantation therapeutics market sizing
• Kidney transplantation therapeutics market forecast
• Kidney transplantation therapeutics market industry analysis

This robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading kidney transplantation therapeutics market vendors that include AbbVie Inc., Asahi Kasei Corp., Astellas Pharma Inc., B Braun Melsungen AG, Bristol Myers Squibb Co., Dr. Reddys Laboratories Ltd., F. Hoffmann La Roche Ltd., Fresenius Medical Care AG and Co. KGaA, GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd., Hansa Biopharma AB, Lifeline Scientific Inc., Novartis AG, Pfizer Inc., Preservation Solution Inc., Sanofi SA, Strides Pharma Science Ltd., TFF Pharmaceuticals Inc., TolerogenixX GmbH, and Transonic Systems Inc. Also, the kidney transplantation therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Read the full report: https://www.reportlinker.com/p06272634/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting